AI Clinical Drug Development Tool
How does UnlearnAI help accelerate clinical trial timelines?
UnlearnAI enables design and execution of smaller randomized controlled trials that maintain power or boost it without needing additional study participants. The approach is EMA-qualified and aligns with current FDA guidance, helping shorten timelines and reduce costs.
How do digital twins work in UnlearnAI's platform?
Digital Twin Generators create disease-specific ML models trained on extensive historical clinical data to generate a digital twin for each trial participant using only their baseline data. These twins forecast clinical outcomes at every future time point with high precision.
How does the platform support faster, better decision-making during a trial?
The platform lets you explore predicted outcomes for any subgroup of participants for all measured clinical outcomes at any point in time, supporting interim analyses and other critical decisions throughout the study.
What is Trial Design Optimization and how does it help?
Trial Design Optimization uses digital twins to refine inclusion/exclusion criteria and clinical endpoints, enabling more efficient trials with a higher chance of success.
In which disease areas does UnlearnAI operate?
The platform supports research in neuroscience (including Alzheimer’s disease), immunology, metabolic disease, and more.
Are digital twins created using each participant’s baseline data only?
Yes. Digital twins are generated for each trial participant using only their baseline data.
What real-world results does the site cite?
The site highlights real-world results with approximate values for metrics like control arm size reduction and enrollment time saved, though exact numbers are not specified in the provided content.
How does UnlearnAI handle privacy and data security?
Unlearn.AI has a Privacy Notice describing how they collect, use, and disclose information, including data provided by users and automatically collected data. The approach emphasizes safeguards, regulatory considerations, and awareness of privacy risks and the importance of consent and data protection.
Is UnlearnAI aligned with regulatory guidance?
Yes. The platform’s approach is EMA-qualified and aligns with current FDA guidance.
How can I learn more or engage with UnlearnAI?
The site invites collaboration with biopharma and provides contact options and information about partnerships to discuss how UnlearnAI can support a study.
